Bradley Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bradley Chen has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Bomar Rojas Mendez
International Health Program, National Yang Ming University, Taipei, Taiwan
2 shared publications- Chin-Chi Kuo
Big Data Center, China Medical University Hospital, China Medical University, Taichung, Taiwan
2 shared publications Miriam Adoyo Muga
Department of Foods, Nutrition and Dietetics, School of Science and Technology, University of Eastern Africa, Baraton, Eldoret, Kenya
2 shared publications- Patrick Opiyo Owili
African Population and Health Research Center (APHRC)
2 shared publications Annie Y. Chen
RAND Corporation, Santa Monica, CA, USA
1 shared publication- Chen-Yuan Chiang
Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, 111 Hsin-Long Road, Section 3, Taipei City, 116, Taiwan; Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, 250 Wuxing Street, Xinyi District, Taipei City, 110, Taiwan
1 shared publication
Latest Publications
- Open Access
- 18 June 2026
- Published by Elsevier in SSRN Electronic Journal
Estimating Catastrophic Total Costs among TB-Affected Households in Taiwan: Implications for the End TB Strategy in High-Income Settings
Background: Economic burdens of tuberculosis (TB) in high-income settings remain overlooked. None of the 40 countries reporting TB cost surveys to the World Health Organization (WHO) were high-income. We conducted the first such survey in a high-income country, Taiwan, to assess WHO End TB Strategy’s zero catastrophic total cost target.Methods: Nationwide cross-sectional survey data were collected from households sampled from 2018 National TB Registry. Following WHO’s protocol, we extrapolated costs throughout the TB episode. Catastrophic total cost was defined as total costs, consisting of direct medical and direct non-medical and indirect costs, exceeding 20% of annual household income. Predictors of catastrophic total cost were assessed using multivariable logistic regression.Findings: Of 481 people with drug-susceptible TB (DS‑TB) and 64 with multidrug-resistant TB (MDR‑TB), 72% were male; mean age was 65. Mean total costs (95% Confidence Interval, CI) were US$2,316 (US$2,083-2,550) for DS‑TB and US$6,665 (US$4,460-8,869) for MDR‑TB. For DS‑TB, indirect, non‑medical, and medical costs comprised 57%, 29%, and 14%; for MDR‑TB, 67%, 29%, and 4%. Catastrophic total cost affected 23% (95% CI: 19-27%) of DS‑TB households and 52% (39-64%) of MDR‑TB households. Household income below the minimum cost of living, diagnosis of MDR-TB, and lack of private health insurance were the predictors of catastrophic total costs.Interpretation: Despite the well-functioning national TB program and national health insurance, a subset of TB-affected households in Taiwan faced substantial financial burdens. Integrated strategies tailored to different cost components are essential to achieve the End TB goal.
- 18 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEstimating Catastrophic Total Costs among TB-Affected Households in Taiwan: Implications for the End TB Strategy in High-Income Settings
Background: Economic burdens of tuberculosis (TB) in high-income settings remain overlooked. None of the 40 countries reporting TB cost surveys to the World Health Organization (WHO) were high-income. We conducted the first such survey in a high-income country, Taiwan, to assess WHO End TB Strategy’s zero catastrophic total cost target.Methods: Nationwide cross-sectional survey data were collected from households sampled from 2018 National TB Registry. Following WHO’s protocol, we extrapolated costs throughout the TB episode. Catastrophic total cost was defined as total costs, consisting of direct medical and direct non-medical and indirect costs, exceeding 20% of annual household income. Predictors of catastrophic total cost were assessed using multivariable logistic regression.Findings: Of 481 people with drug-susceptible TB (DS‑TB) and 64 with multidrug-resistant TB (MDR‑TB), 72% were male; mean age was 65. Mean total costs (95% Confidence Interval, CI) were US$2,316 (US$2,083-2,550) for DS‑TB and US$6,665 (US$4,460-8,869) for MDR‑TB. For DS‑TB, indirect, non‑medical, and medical costs comprised 57%, 29%, and 14%; for MDR‑TB, 67%, 29%, and 4%. Catastrophic total cost affected 23% (95% CI: 19-27%) of DS‑TB households and 52% (39-64%) of MDR‑TB households. Household income below the minimum cost of living, diagnosis of MDR-TB, and lack of private health insurance were the predictors of catastrophic total costs.Interpretation: Despite the well-functioning national TB program and national health insurance, a subset of TB-affected households in Taiwan faced substantial financial burdens. Integrated strategies tailored to different cost components are essential to achieve the End TB goal.
- Open Access
- 12 November 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-10
Better continuity of care improves the quality of end-of-life care among elderly patients with end-stage renal disease
Continuity of care (COC) has been emphasized in research on terminal cancer patients to increase the quality of end-of-life care; however, limited research has been conducted on end-stage renal disease patients. We applied a retrospective cohort design on 29,095 elderly patients with end-stage renal disease who died between 2005 and 2013. These patients were identified from the National Health Insurance Research Database of Taiwan. The provider Continuity of Care Index (COCI) and site COCI were calculated on the basis of outpatient visits during the 6–12 months before death. We discovered that increases in the provider COCI were significantly associated with reductions in health expenditures after adjusting for confounders, especially in inpatient and emergency departments, where the treatment intensity is high. Higher provider and site COC were also associated with lower utilization of acute care and invasive treatments in the last month before death. Provider COC had a greater effect on end-of-life care expenditures than site COC did, which indicated significant care coordination gaps within the same facility. Our findings support the recommendation of prioritizing the continuity of end-of-life care, especially provider continuity, for patients with end-stage renal disease.
- 12 November 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-10
Open AccessBetter continuity of care improves the quality of end-of-life care among elderly patients with end-stage renal disease
Continuity of care (COC) has been emphasized in research on terminal cancer patients to increase the quality of end-of-life care; however, limited research has been conducted on end-stage renal disease patients. We applied a retrospective cohort design on 29,095 elderly patients with end-stage renal disease who died between 2005 and 2013. These patients were identified from the National Health Insurance Research Database of Taiwan. The provider Continuity of Care Index (COCI) and site COCI were calculated on the basis of outpatient visits during the 6–12 months before death. We discovered that increases in the provider COCI were significantly associated with reductions in health expenditures after adjusting for confounders, especially in inpatient and emergency departments, where the treatment intensity is high. Higher provider and site COC were also associated with lower utilization of acute care and invasive treatments in the last month before death. Provider COC had a greater effect on end-of-life care expenditures than site COC did, which indicated significant care coordination gaps within the same facility. Our findings support the recommendation of prioritizing the continuity of end-of-life care, especially provider continuity, for patients with end-stage renal disease.
- 1 July 2019
- Published by Elsevier in Social Science & Medicine
- Vol. 233, 272-280
Managing health expenditure inflation under a single-payer system: Taiwan's National Health Insurance
- 1 July 2019
- Published by Elsevier in Social Science & Medicine
- Vol. 233, 272-280
Managing health expenditure inflation under a single-payer system: Taiwan's National Health Insurance
- Open Access
- 11 May 2018
- Published by Oxford University Press (OUP) in International Journal for Quality in Health Care
- Vol. 31 (1) , 43-48
Quality of care in six sub-Saharan Africa countries: a provider-based study on adherence to WHO’s antenatal care guideline
Quality of care may help explain the high burden of disease in maternal, newborn and child health in low- and middle-income countries even as access to care is improved. We explored the determinants of quality of antenatal care (ANC) in sub-Saharan Africa (SSA). Cross-sectional study. Multilevel Generalized Linear Latent Mixed-Effect models with logit link function were employed to obtain the adjusted odds ratios (AORs) and 95% confidence interval (CI). We used Service Provision Assessment data from six countries in SSA, including Kenya, Malawi, Namibia, Rwanda, Tanzania and Uganda. Seven thousand, five hundred and seventy seven observed antenatal clients across the six countries. Quality of ANC services, measured using indexes of quality of clinical care and quality of information provided. Providers in facilities that had ANC guideline (AOR = 1.26; 95% CI, 1.08–1.48), were well-equipped (AOR = 1.65; 95% CI, 1.41–1.92), were classified as upper level facility (AOR = 1.32; 95% CI, 1.05–1.66), had central electricity supply (AOR = 2.19; 95% CI, 1.81–2.65), and piped water (AOR = 1.30; 95% CI, 1.09–1.55) were more likely to provide optimal quality of clinical care. Moreover, those having ANC guideline (AOR = 1.81; 95% CI, 1.43–2.28) and central electricity supply (AOR = 2.67; 95% CI, 2.01–3.44) were more likely to provide optimal information as well. Provider’s qualification and experience were also important in information provision and clinical care independently. The lack of some very basic facility equipment and amenities compromised quality of care in sub-Saharan countries. Policy actions and investment on facility and providers will enable provision of quality services necessary to improve maternal, newborn and child health in SSA.
- 11 May 2018
- Published by Oxford University Press (OUP) in International Journal for Quality in Health Care
- Vol. 31 (1) , 43-48
Open AccessQuality of care in six sub-Saharan Africa countries: a provider-based study on adherence to WHO’s antenatal care guideline
Quality of care may help explain the high burden of disease in maternal, newborn and child health in low- and middle-income countries even as access to care is improved. We explored the determinants of quality of antenatal care (ANC) in sub-Saharan Africa (SSA). Cross-sectional study. Multilevel Generalized Linear Latent Mixed-Effect models with logit link function were employed to obtain the adjusted odds ratios (AORs) and 95% confidence interval (CI). We used Service Provision Assessment data from six countries in SSA, including Kenya, Malawi, Namibia, Rwanda, Tanzania and Uganda. Seven thousand, five hundred and seventy seven observed antenatal clients across the six countries. Quality of ANC services, measured using indexes of quality of clinical care and quality of information provided. Providers in facilities that had ANC guideline (AOR = 1.26; 95% CI, 1.08–1.48), were well-equipped (AOR = 1.65; 95% CI, 1.41–1.92), were classified as upper level facility (AOR = 1.32; 95% CI, 1.05–1.66), had central electricity supply (AOR = 2.19; 95% CI, 1.81–2.65), and piped water (AOR = 1.30; 95% CI, 1.09–1.55) were more likely to provide optimal quality of clinical care. Moreover, those having ANC guideline (AOR = 1.81; 95% CI, 1.43–2.28) and central electricity supply (AOR = 2.67; 95% CI, 2.01–3.44) were more likely to provide optimal information as well. Provider’s qualification and experience were also important in information provision and clinical care independently. The lack of some very basic facility equipment and amenities compromised quality of care in sub-Saharan countries. Policy actions and investment on facility and providers will enable provision of quality services necessary to improve maternal, newborn and child health in SSA.
- Open Access
- 16 May 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (5) , e0177756
Quality of maternity care and its determinants along the continuum in Kenya: A structural equation modeling analysis
Improving access to delivery services does not guarantee access to quality obstetric care and better survival, and therefore, concerns for quality of maternal and newborn care in low- and middle-income countries have been raised. Our study explored characteristics associated with the quality of initial assessment, intrapartum, and immediate postpartum and newborn care, and further assessed the relationships along the continuum of care. The 2010 Service Provision Assessment data of Kenya for 627 routine deliveries of women aged 15–49 were used. Quality of care measures were assessed using recently validated quality of care measures during initial assessment, intrapartum, and postpartum periods. Data were analyzed with negative binomial regression and structural equation modeling technique. The negative binomial regression results identified a number of determinants of quality, such as the level of health facilities, managing authority, presence of delivery fee, central electricity supply and clinical guideline for maternal and neonatal care. Our structural equation modeling (SEM) further demonstrated that facility characteristics were important determinants of quality for initial assessment and postpartum care, while characteristics at the provider level became more important in shaping the quality of intrapartum care. Furthermore we also noted that quality of initial assessment had a positive association with quality of intrapartum care (β = 0.71, p < 0.001), which in turn was positively associated with the quality of newborn and immediate postpartum care (β = 1.29, p = 0.004). A continued focus on quality of care along the continuum of maternity care is important not only to mothers but also their newborns. Policymakers should therefore ensure that required resources, as well as adequate supervision and emphasis on the quality of obstetric care, are available.
- 16 May 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (5) , e0177756
Open AccessQuality of maternity care and its determinants along the continuum in Kenya: A structural equation modeling analysis
Improving access to delivery services does not guarantee access to quality obstetric care and better survival, and therefore, concerns for quality of maternal and newborn care in low- and middle-income countries have been raised. Our study explored characteristics associated with the quality of initial assessment, intrapartum, and immediate postpartum and newborn care, and further assessed the relationships along the continuum of care. The 2010 Service Provision Assessment data of Kenya for 627 routine deliveries of women aged 15–49 were used. Quality of care measures were assessed using recently validated quality of care measures during initial assessment, intrapartum, and postpartum periods. Data were analyzed with negative binomial regression and structural equation modeling technique. The negative binomial regression results identified a number of determinants of quality, such as the level of health facilities, managing authority, presence of delivery fee, central electricity supply and clinical guideline for maternal and neonatal care. Our structural equation modeling (SEM) further demonstrated that facility characteristics were important determinants of quality for initial assessment and postpartum care, while characteristics at the provider level became more important in shaping the quality of intrapartum care. Furthermore we also noted that quality of initial assessment had a positive association with quality of intrapartum care (β = 0.71, p < 0.001), which in turn was positively associated with the quality of newborn and immediate postpartum care (β = 1.29, p = 0.004). A continued focus on quality of care along the continuum of maternity care is important not only to mothers but also their newborns. Policymakers should therefore ensure that required resources, as well as adequate supervision and emphasis on the quality of obstetric care, are available.
- Open Access
- 26 January 2017
- Published by Springer Nature in BMC Nephrology
- Vol. 18 (1) , 36
Costs of care at the end of life among elderly patients with chronic kidney disease: patterns and predictors in a nationwide cohort study
Despite the urgent need for evidence to guide the end-of-life (EOL) care for patients with chronic kidney disease (CKD), we have limited knowledge of the costs and intensity of EOL care in this population. The present study examined patterns and predictors for EOL care intensity among elderly patients with CKD. We conducted a retrospective nationwide cohort study utilizing the Taiwan National Health Insurance (NHI) Research Database. A total of 65,124 CKD patients aged ≥ 60 years, who died in hospitals or shortly after discharge between 2002 and 2012 were analyzed. The primary outcomes were inpatient expenses and use of surgical interventions in the last 30 days of life. Utilization of intensive care unit (ICU), mechanical ventilation, resuscitation, and dialysis was also examined in a sub-sample of 2072 patients with detailed prescription data. Multivariate log-linear and logistic regression analyses were performed to assess patient-, physician-, and facility-specific predictors and the potential impact of a 2009 payment policy to reimburse hospice care for non-cancer patients. During the last 30 days of life, average inpatients costs for elderly CKD patients were approximately US$10,260, with 40.9% receiving surgical interventions, 40.2% experiencing ICU admission, 45.3% undergoing mechanical ventilation, 14.7% receiving resuscitation and 42.0% receiving dialysis. Significant variability was observed in the inpatient costs and use of intensive services. Costs were lower among individuals with the following characteristics: advanced age; high income; high Charlson Comorbidity Index scores; treatment by older physicians, nephrologists, and family medicine physicians; and treatment at local hospitals. Similar findings were obtained for the use of surgical interventions and other intensive services. A declining trend was detected in the costs of EOL care, use of surgical interventions and resuscitation between 2009 and 2012, which is consistent with the impact of a 2009 NHI payment policy to reimburse non-cancer hospice care. Overall EOL costs and rates of intensive service use among older patients with CKD were high, with significant variability across various patient and provider characteristics. Several opportunities exist for providers and policy makers to reduce costs and enhance the value of EOL care for this population.
- 26 January 2017
- Published by Springer Nature in BMC Nephrology
- Vol. 18 (1) , 36
Open AccessCosts of care at the end of life among elderly patients with chronic kidney disease: patterns and predictors in a nationwide cohort study
Despite the urgent need for evidence to guide the end-of-life (EOL) care for patients with chronic kidney disease (CKD), we have limited knowledge of the costs and intensity of EOL care in this population. The present study examined patterns and predictors for EOL care intensity among elderly patients with CKD. We conducted a retrospective nationwide cohort study utilizing the Taiwan National Health Insurance (NHI) Research Database. A total of 65,124 CKD patients aged ≥ 60 years, who died in hospitals or shortly after discharge between 2002 and 2012 were analyzed. The primary outcomes were inpatient expenses and use of surgical interventions in the last 30 days of life. Utilization of intensive care unit (ICU), mechanical ventilation, resuscitation, and dialysis was also examined in a sub-sample of 2072 patients with detailed prescription data. Multivariate log-linear and logistic regression analyses were performed to assess patient-, physician-, and facility-specific predictors and the potential impact of a 2009 payment policy to reimburse hospice care for non-cancer patients. During the last 30 days of life, average inpatients costs for elderly CKD patients were approximately US$10,260, with 40.9% receiving surgical interventions, 40.2% experiencing ICU admission, 45.3% undergoing mechanical ventilation, 14.7% receiving resuscitation and 42.0% receiving dialysis. Significant variability was observed in the inpatient costs and use of intensive services. Costs were lower among individuals with the following characteristics: advanced age; high income; high Charlson Comorbidity Index scores; treatment by older physicians, nephrologists, and family medicine physicians; and treatment at local hospitals. Similar findings were obtained for the use of surgical interventions and other intensive services. A declining trend was detected in the costs of EOL care, use of surgical interventions and resuscitation between 2009 and 2012, which is consistent with the impact of a 2009 NHI payment policy to reimburse non-cancer hospice care. Overall EOL costs and rates of intensive service use among older patients with CKD were high, with significant variability across various patient and provider characteristics. Several opportunities exist for providers and policy makers to reduce costs and enhance the value of EOL care for this population.
- Open Access
- 1 December 2015
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (51) , e2175
Prevalence of Metformin Use and the Associated Risk of Metabolic Acidosis in US Diabetic Adults With CKD
The use of metformin in chronic kidney disease (CKD) population has been intensely debated with conflicting evidence. Large population studies are needed to inform risk assessment and therapeutic decision-making. We evaluated the associations among metformin, metabolic acidosis, and CKD in a 10-year nationally representative noninstitutionalized civilian population in the United States. In this cross-sectional study, a total of 2279 diabetic adults aged 20 years or older in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2012 were included and had measurements of serum bicarbonate, sodium, potassium, and chloride. The exposure was metformin use. The outcome was subclinical and severe metabolic acidosis defined by serum bicarbonate 16mEq/L and by serum bicarbonate < 20 mEq/L, respectively. The prevalence of metformin use decreased from 67.2% among CKD-1 and -2, 40.6% among CKD-3, to 1.3% among advanced CKD-4 and -5. Across CKD stages up to CKD-3b, we observed a tendency of lower levels of serum bicarbonate that was significant in metformin users with CKD-2 and CKD-3a and marginally significant with CKD-3b compared to nonmetformin users. The corresponding tendency of higher anion gap in metformin users with the estimated glomerular filtration rate >60 mL/min/1.73 m2 was also observed. In multiple linear regression analysis, metformin was significantly associated with decreased serum bicarbonate levels (β = −0.45, 95% CI: −0.73, −0.17) and increased serum anion gap levels (β = 0.40, 95% CI: 0.19, 0.61). The adjusted odds ratio of subclinical high anion gap and severe metabolic acidosis for metformin users was 1.68 (95% CI: 1.11, 2.55) and 1.31 (0.49, 3.47), respectively. The association between metformin and serum bicarbonate was significantly modified by CKD status. No interaction was found between metformin and CKD stages for serum anion gap and acidosis. Metformin is associated with subclinical metabolic acidosis but not with severe metabolic acidosis. The propensity of serum bicarbonate-lowering effect was intensified in advanced CKD; however, such tendency was not associated with the risk of clinically defined acidosis. Our findings highlight a potential of cautious expansion of metformin use among CKD-3b patients with diabetes meriting further investigations.
- 1 December 2015
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (51) , e2175
Open AccessPrevalence of Metformin Use and the Associated Risk of Metabolic Acidosis in US Diabetic Adults With CKD
The use of metformin in chronic kidney disease (CKD) population has been intensely debated with conflicting evidence. Large population studies are needed to inform risk assessment and therapeutic decision-making. We evaluated the associations among metformin, metabolic acidosis, and CKD in a 10-year nationally representative noninstitutionalized civilian population in the United States. In this cross-sectional study, a total of 2279 diabetic adults aged 20 years or older in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2012 were included and had measurements of serum bicarbonate, sodium, potassium, and chloride. The exposure was metformin use. The outcome was subclinical and severe metabolic acidosis defined by serum bicarbonate 16mEq/L and by serum bicarbonate < 20 mEq/L, respectively. The prevalence of metformin use decreased from 67.2% among CKD-1 and -2, 40.6% among CKD-3, to 1.3% among advanced CKD-4 and -5. Across CKD stages up to CKD-3b, we observed a tendency of lower levels of serum bicarbonate that was significant in metformin users with CKD-2 and CKD-3a and marginally significant with CKD-3b compared to nonmetformin users. The corresponding tendency of higher anion gap in metformin users with the estimated glomerular filtration rate >60 mL/min/1.73 m2 was also observed. In multiple linear regression analysis, metformin was significantly associated with decreased serum bicarbonate levels (β = −0.45, 95% CI: −0.73, −0.17) and increased serum anion gap levels (β = 0.40, 95% CI: 0.19, 0.61). The adjusted odds ratio of subclinical high anion gap and severe metabolic acidosis for metformin users was 1.68 (95% CI: 1.11, 2.55) and 1.31 (0.49, 3.47), respectively. The association between metformin and serum bicarbonate was significantly modified by CKD status. No interaction was found between metformin and CKD stages for serum anion gap and acidosis. Metformin is associated with subclinical metabolic acidosis but not with severe metabolic acidosis. The propensity of serum bicarbonate-lowering effect was intensified in advanced CKD; however, such tendency was not associated with the risk of clinically defined acidosis. Our findings highlight a potential of cautious expansion of metformin use among CKD-3b patients with diabetes meriting further investigations.
- 1 October 2015
- Published by Elsevier in Health Policy
- Vol. 119 (10) , 1382-1389
Does prenatal care benefit maternal health? A study of post-partum maternal care use
- 1 October 2015
- Published by Elsevier in Health Policy
- Vol. 119 (10) , 1382-1389
Does prenatal care benefit maternal health? A study of post-partum maternal care use